Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43,411,663
-
Total 13F shares
-
1,844,607
-
Share change
-
+1,844,607
-
Total reported value
-
$25,915,405
-
Price per share
-
$14.05
-
Number of holders
-
28
-
Value change
-
+$25,915,405
-
Number of buys
-
28
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q1 2018
As of 31 Mar 2018,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,844,607 shares.
The largest 10 holders included
First Eagle Investment Management, LLC, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, CITIGROUP INC, P.A.W. CAPITAL CORP, MORGAN STANLEY, and Bank of New York Mellon Corp.
This page lists
28
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.